Variant report

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:178771023..178773697-chr2:178777397..178779735,2	K562	blood:

rSNPs within LD-proxies of this variant (count:29)

rs_ID	r²[population]
rs10930813	0.82[YRI][hapmap]
rs1370657	0.88[YRI][hapmap];0.85[AFR][1000 genomes]
rs1438052	1.00[YRI][hapmap];0.90[AFR][1000 genomes]
rs1898588	1.00[YRI][hapmap];0.85[AFR][1000 genomes]
rs2573086	0.84[AFR][1000 genomes]
rs2695095	1.00[YRI][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs2695096	1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs2695106	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs2695114	0.88[AFR][1000 genomes]
rs2695720	1.00[YRI][hapmap];0.90[AFR][1000 genomes]
rs2695721	1.00[YRI][hapmap];0.90[AFR][1000 genomes]
rs2695723	1.00[YRI][hapmap]
rs2695725	1.00[YRI][hapmap]
rs2695759	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56189218	0.85[AFR][1000 genomes]
rs56230218	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs56300810	0.88[AFR][1000 genomes]
rs6433700	1.00[YRI][hapmap];0.83[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs6712039	0.89[YRI][hapmap];0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs6752913	0.88[YRI][hapmap];0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73972662	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73972663	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73972665	1.00[AMR][1000 genomes]
rs73972667	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73972668	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73972669	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs7570577	0.80[YRI][hapmap]
rs9283485	1.00[YRI][hapmap];0.85[AFR][1000 genomes]
rs934806	0.88[YRI][hapmap]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv533377	chr2:178718801-178963463	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers ZNF genes & repeats Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
2	nsv1007579	chr2:178729330-178890946	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
3	nsv875451	chr2:178748294-178953409	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
4	nsv998304	chr2:178756380-178924378	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
5	nsv536056	chr2:178756380-178924378	Enhancers Weak transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:3 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:178768600-178780000	Weak transcription	Psoas Muscle	Psoas
2	chr2:178777600-178781200	Enhancers	Skeletal Muscle Female	skeletal muscle
3	chr2:178778200-178780400	Enhancers	Skeletal Muscle Male	skeletal muscle

Quick Search: